FMH Oncology Services Welcomes Dr. Hertler
September 7, 2007
Dr. Andrew Hertler
Franklin Memorial Hospital (FMH) is pleased to announce a new partnership with MaineGeneral's Harold Alfond Center for Cancer Care with the arrival of Dr. Andrew Hertler, a medical oncologist and hematologist, who will be providing cancer care at Franklin Memorial Hospital starting September 13.
In addition to treating cancer patients at the Farmington hospital, Dr. Hertler also serves as medical director of the Harold Alfond Center for Cancer Care in Augusta. The new $42 million outpatient center opened for patients on July 9. At its grand opening, Dr. Hertler promised treatment "at
the cutting-edge-of-science" to best serve its patients and set the standard for cancer treatment. Dr. Hertler has practiced in Central Maine since 1996.
We are pleased to have this new partnership with Dr. Hertler and his team from the Harold Alfond Center," said Gerald Cayer, Franklin Community Health Network Executive Vice President and FMH Chief Operating Officer. "It reflects a strategic focus in partnering with health systems with unique and quality medical services. This new partnership will benefit the patient and the patient's family, as well as the medical staff and the nursing service."
"Dr. Hertler employs a sophisticated approach to combating cancer that is usually found only in large, teaching hospitals," said Taffy Davis, FMH Outpatient and Oncology Manager. "He will provide chemotherapy and other medical therapies to treat and manage the disease and its symptoms on an outpatient basis. The staff is excited to work with Dr. Hertler and embrace his philosophy of cancer care."
Dr. Hertler is board certified in Internal Medicine and Medical Oncology. He is affiliated with the American Society of Hematology, as well as the American Society of Clinical Oncology.
Dr. Hertler's professional interests include general medical oncology, clinical trials, and research aimed at development of "Best Practices in Community Cancer Programs." He received his medical degree from the University of Michigan and completed his residency at University of Michigan
affiliated hospitals. He later completed an oncology Fellowship at Duke University Medical Center in Durham, North Carolina.
"We are pleased to offer aggressive treatment for all types of cancer, as well as benign and malignant blood disorders," said Davis. "We offer chemotherapy and intravenous fluids administration and blood product transfusion, all administered by chemotherapy-certified and oncology-certified registered nurses.
FMH also participates in clinical trials. Clinical trials are research for new and better cancer care, which are accessed through the Dana Farber Cancer Institute and Dartmouth Hitchcock Medical Center through the Harold Alfond Center for Cancer Care.
For more information, contact Taffy Davis at 779-2811.
Subscribe to our RSS news feed